Publication Name	World Journal of Gastroenterology
Manuscript ID	52065
Country	Germany

Received	2019-10-15 09:14
Peer-Review Started	2019-10-15 09:14
To Make the First Decision
Return for Revision	2019-12-04 20:13
Revised	2019-12-17 07:29
Second Decision	2019-12-30 05:43
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2020-01-01 23:14
Articles in Press	2020-01-01 23:14
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2020-01-14 00:59
Publish the Manuscript Online	2020-01-16 07:58

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Fibroblast growth factor signaling in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Paving the way to hepatocellular carcinoma
Manuscript Source	Invited Manuscript
All Author List	Matthias Ocker
ORCID	Author(s) ORCID Number Matthias Ocker http://orcid.org/0000-0001-8263-6288
Funding Agency and Grant Number
Corresponding Author	Matthias Ocker, MD, Professor, Department of Gastroenterology, CBF, Charité University Medicine Berlin, Chariteplatz 1, Berlin 10117, Germany. matthiasocker@gmail.com
Key Words	Fibroblast growth factor; Fibroblast growth factor receptor; Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Fibrosis; Cirrhosis
Core Tip	Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis show globally rising incidences and are expected to become the main reason for liver fibrosis, cirrhosis, liver cancer and end-stage liver disease with need for transplantation. Liver metabolism is, among other factors, regulated by fibroblast growth factors and their receptors. This review highlights the role of these signaling pathways in the context of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis and discusses novel treatment options for these otherwise difficult to treat diseases.
Publish Date	2020-01-16 07:58
Citation	Ocker M. Fibroblast growth factor signaling in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Paving the way to hepatocellular carcinoma. World J Gastroenterol 2020; 26(3): 279-290
URL	https://www.wjgnet.com/1007-9327/full/v26/i3/279.htm
DOI	https://dx.doi.org/10.3748/wjg.v26.i3.279

Full Article (PDF)	WJG-26-279.pdf
Full Article (Word)	WJG-26-279.docx
Manuscript File	52065-Review.docx
Answering Reviewers	52065-Answering reviewers.pdf
Audio Core Tip	52065-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	52065-Conflict-of-interest statement.pdf
Copyright License Agreement	52065-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	52065-Language certificate.pdf
Peer-review Report	52065-Peer-review(s).pdf
Scientific Misconduct Check	52065-Scientific misconduct check.pdf
Scientific Editor Work List	52065-Scientific editor work list.pdf
CrossCheck Report	52065-CrossCheck report.pdf